|Free Dividend Report|
|Stock Splits Calendar|
|ABIO Historical Stock Prices|
|Preferred Stock Newsletter|
|ABIO Options Chain|
|Stock Message Boards|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on November 22, 2023, ABIO opened at $1.89, traded as high as $1.89 and as low as $1.85, and closed at $1.87. Trading volume was a total of 12.50K shares. On November 24, 2023, ABIO opened at $1.86, traded as high as $1.95 and as low as $1.86, and closed at $1.95. Trading volume was a total of 23.50K shares. On November 27, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.91, and closed at $1.94. Trading volume was a total of 12.40K shares. On November 28, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.89, and closed at $1.90. Trading volume was a total of 6.00K shares. On November 29, 2023, ABIO opened at $1.88, traded as high as $1.94 and as low as $1.88, and closed at $1.90. Trading volume was a total of 28.40K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-36.49%|
|ABIO Historical Price Range|
|About ARCA biopharma|
|ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.|
|ABIO Historical Closing Prices|
|Healthcare Historical Prices|
|ABIO is categorized under the Healthcare sector; below are some other companies in the same sector:
ABMD Historical Stock Prices
Also explore: ABIO shares outstanding history
ABIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights ReservedNothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.